Gynecologic Cancer

Trametinib should be a new standard of care for women with recurrent low-grade serous carcinoma, according to study published in The Lancet that showed a 52% reduction in risk for disease progression or death vs. current treatment options.

Lenvatinib plus pembrolizumab conferred significantly longer PFS and OS than chemotherapy among women with advanced endometrial cancer, according to randomized, phase 3 trial results published in The New England Journal of Medicine.

Balstilimab plus zalifrelimab demonstrated promising and durable activity among women with recurrent and/or metastatic cervical cancer who relapsed after platinum-based therapy, according to a phase 2 study in Journal of Clinical Oncology.

Pembrolizumab showed strong and lasting antitumor activity in women with previously treated, advanced microsatellite instability-high or mismatch repair-deficient endometrial cancer, according to a study in Journal of Clinical Oncology.

In the final installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about which adults may derive the most benefit from catch-up HPV vaccination.

In the third installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about how clinicians can help overcome HPV vaccine hesitancy.

In the second installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the impact of HPV vaccination on the global burden of cervical cancer.

In the first installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the importance of HPV vaccination.

Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association especially strong in colon, lung, ovarian and stomach cancers, according to a nested case-control study in JAMA Network Open.

There are many major life events that can be as exciting as they are demanding, such as starting the next step in a career or having a child — both of which two oncologist colleagues experienced around the same time.